Skip to main content
. 2018 May 22;9(6):599. doi: 10.1038/s41419-018-0623-9

Fig. 5. Sal-B inhibited the aberrant glucose metabolism.

Fig. 5

(A,B) Measurement of glucose intracellular and in supernatants treated with 0, 150, and 250 uM of Sal-B. (C,D) Measurement of lactate intracellular and in supernatants treated with 0, 150, and 250 uM of Sal-B. P<0.05 was considered statistically significant, ns P>0.05, *P<0.05, **P<0.01, ***P<0.001 vs control group.